mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.03 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.03 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.04 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |